Metoprolol Tartrate
NDC Package 67296-0729-9

11-digit billing NDC: 67296072909

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Metoprolol Tartrate is hypertensionMetoprolol tartrate tablets are indicated for the treatment of hypertension. Marketed by Redpharm Drug Inc., this product is identified by NDC 67296-0729 and is authorized under FDA application ANDA076670.

Identification & Billing

NDC Package Code
67296-0729-9
Package Description
90 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
67296072909
RxNorm Crosswalk
RxCUI: 866924 - metoprolol tartrate 25 MG Oral Tablet

Clinical Specifications

Proprietary Name
Metoprolol Tartrate
Dosage Form
-
Usage Information
HypertensionMetoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.Angina PectorisMetoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris.Myocardial InfarctionMetoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol tartrate. Oral metoprolol tartrate therapy can be initiated after intravenous metoprolol tartrate therapy, or alternatively, oral treatment can begin within 3 to 10 days of acute event (see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, and WARNINGS).

Regulatory & Marketing

Labeler Name
Redpharm Drug Inc.
FDA Application #
ANDA076670
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-29-2015
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67296-0729). Click a package code to view its specific billing and regulatory data.

30 TABLET in 1 BOTTLE
60 TABLET in 1 BOTTLE
120 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-0729-9 identifies a specific commercial package of 90 tablet in 1 bottle of Metoprolol Tartrate, labeled by Redpharm Drug Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug Inc. on June 29, 2015. The current certification is valid through December 31, 2025.

How is this Redpharm Drug Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296072909. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-0729-9
11-Digit CMS (5-4-2)
67296-0729-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.